Glaucoma: Early Symptoms, Diagnosis, Treatment and Prevention of Vision Loss

Reviewed: 8 November 2026
Reading time: Approximately 6 minutes

Glaucoma is a group of eye diseases in which characteristic damage to the optic nerve can lead to irreversible vision loss. It is often linked to elevated intraocular pressure (IOP), but glaucoma can also occur when pressure measurements fall within the usual population range. Much of the damage develops without pain or early symptoms. The central goal of care is therefore early detection and prevention of further optic-nerve damage, rather than waiting for vision to deteriorate.[1,2]

What happens in glaucoma?

The optic nerve carries signals from the retina to the brain. In glaucoma, retinal nerve fibres are progressively lost and visual-field defects may develop. Eye pressure is determined partly by how aqueous humour is produced and drains through the trabecular and uveoscleral pathways. IOP reduction is the principal treatment with strong evidence for slowing progression, even though raised pressure is not required for diagnosis.[1,2]

Main types of glaucoma

  • Primary open-angle glaucoma (POAG): The drainage angle is open, but aqueous outflow resistance and susceptibility to optic-nerve damage are important. It typically progresses slowly and silently.
  • Normal-tension glaucoma: Characteristic glaucomatous damage occurs despite pressure readings within the usual statistical range; lowering IOP can still be useful.
  • Primary angle-closure disease: The peripheral iris obstructs drainage structures. It may develop gradually or present as a sudden, painful emergency.
  • Secondary glaucoma: Pressure elevation or nerve damage is associated with causes such as corticosteroid exposure, uveitis, trauma, other eye disorders or certain procedures.
  • Childhood glaucoma: Less common and requires specialist management.[1,2]

What are the symptoms?

Early open-angle glaucoma usually has no noticeable symptoms. Over time, peripheral visual-field loss may develop and, if untreated, central vision can be affected. Patients should not rely on pain, redness or perceived sharpness of sight to judge whether they have glaucoma.[1,2]

Acute angle closure is an emergency. Sudden severe eye pain, headache, a red eye, blurred vision, halos around lights, and nausea or vomiting require immediate emergency ophthalmic assessment. Treatment aims to lower pressure rapidly and relieve the obstruction; definitive laser or surgical management may be required. Do not wait for a scheduled eye check.[1,2]

Who is at increased risk?

Risk factors include older age, a first-degree relative with glaucoma, elevated IOP, certain optic-nerve findings, myopia or other anatomical factors, and population-specific differences in risk. A thin central cornea may complicate pressure interpretation and is also relevant to risk assessment. Long-term corticosteroid use, including some eye drops, injections, inhaled or systemic regimens, can raise pressure in susceptible individuals. Risk varies with route, exposure and patient characteristics.[1,2]

There is no proven home treatment or supplement that reliably prevents glaucoma. People at increased risk should discuss the appropriate frequency of comprehensive dilated eye examinations with an eye-care professional. Avoid stopping medically necessary corticosteroids on your own; discuss eye-pressure monitoring with the prescriber.

How is glaucoma diagnosed?

A single pressure measurement does not confirm or exclude glaucoma. A comprehensive assessment may include:

  1. Tonometry to measure IOP, with repeated measurements where indicated.
  2. Optic-nerve examination and imaging, including optical coherence tomography (OCT) to assess retinal nerve-fibre and ganglion-cell layers.
  3. Standard automated visual-field testing to detect functional damage and establish a baseline.
  4. Gonioscopy to determine whether the anterior chamber angle is open or narrow.
  5. Central corneal thickness measurement, evaluation of the optic disc and review of risk factors.

The diagnosis, disease stage and risk of progression inform a personalized target IOP and follow-up schedule. Repeat testing is often essential because individual tests have limitations and slow change can be difficult to recognize.[1,2]

Treatment: how is glaucoma managed?

Selective laser trabeculoplasty (SLT)

SLT uses a laser to improve fluid outflow through the trabecular meshwork. It is not simply a treatment reserved for failure of multiple eye drops. The NICE glaucoma guideline recommends offering 360-degree SLT as an initial treatment option for many patients with newly diagnosed nonadvanced chronic open-angle glaucoma, and for selected people with ocular hypertension who are at sufficient lifetime risk of visual loss. Suitability depends on glaucoma type, anatomy, disease severity and patient preference; a repeat treatment may sometimes be considered.[1]

Pressure-lowering eye drops

When medication is chosen, the aim is to lower IOP sufficiently to reduce progression while minimizing adverse effects. Important drug classes include:

Class Common examples Main action Important cautions
Prostaglandin analogues Latanoprost, travoprost, bimatoprost Increase aqueous-humour outflow, especially uveoscleral outflow Eye redness, eyelash growth, iris/periocular pigmentation; caution with some inflammatory conditions
Beta-blockers Timolol, betaxolol Decrease aqueous-humour production Can cause bradycardia or bronchospasm; may be unsuitable with asthma, certain heart or conduction disorders
Carbonic anhydrase inhibitors Dorzolamide, brinzolamide; oral acetazolamide in selected settings Decrease aqueous production Local irritation; systemic agents have additional renal, electrolyte and other precautions
Alpha-2 agonists Brimonidine Decrease production and can enhance outflow Ocular allergy, fatigue and systemic adverse effects; special caution in children
Rho-kinase inhibitors Netarsudil in markets where available Increase trabecular outflow Conjunctival hyperaemia and corneal adverse effects

The drug chosen is influenced by IOP targets, other illnesses, pregnancy considerations, cost, access, tolerability and adherence. Prostaglandin analogues are commonly used when eye drops are the preferred initial treatment, but SLT is also an evidence-based first-line option for suitable patients.[1,2]

Correct technique matters: after instilling a drop, gently closing the eyelid and applying pressure at the inner corner of the eye for a short period can reduce drainage into the nose and systemic absorption. Avoid touching the bottle tip to the eye. If several drops are prescribed, follow the advised separation interval and regimen.

Surgery

If laser or medication does not achieve sufficient control—or if glaucoma is advanced—surgical options can include trabeculectomy, drainage devices, minimally invasive glaucoma surgery in selected settings, or other procedures. Surgery aims to preserve remaining vision; it generally cannot recover nerve fibres already lost.[1,2]

Monitoring and long-term care

Treatment success is not assessed by pressure alone. Ophthalmologists follow visual fields, optic-nerve appearance, OCT findings and IOP trends. A target pressure may be revised if damage progresses despite the current reading. Some patients need combination therapy, a change of drug, additional SLT or surgery. Consistent follow-up and correct treatment use are crucial because symptoms may remain absent even when damage continues.[1,2]

Can glaucoma-related blindness be prevented?

It is often possible to reduce the risk of severe vision loss through timely diagnosis, pressure lowering and careful monitoring. However, no medicine, vitamin, dietary pattern or exercise program has been shown to prevent all cases or reliably reverse established optic-nerve damage. People at risk should seek eye examinations rather than rely on self-testing or the absence of symptoms.[1,2]

Frequently asked questions

Can I have glaucoma with normal eye pressure?

Yes. Normal-tension glaucoma is a recognized diagnosis. Optic-nerve and visual-field findings are essential; an apparently normal pressure reading is not enough to rule the disease out.

Is glaucoma curable?

There is no general cure that restores damaged optic-nerve tissue. Current therapies aim to slow or halt further deterioration through sustained IOP reduction and monitoring.[1,2]

Does everyone with ocular hypertension need treatment?

No. Treatment depends on overall risk of future visual impairment, not a pressure number alone. Observation is appropriate for some lower-risk individuals; SLT or drops may be offered when the estimated risk justifies treatment.[1]

Key takeaways

Glaucoma commonly progresses without early warning symptoms. Diagnosis relies on comprehensive eye examination and follow-up, not IOP alone. Both SLT and appropriately chosen pressure-lowering medicines are established treatments, with surgery available when indicated. A painful red eye with sudden visual change is a medical emergency.[1,2]

References

  1. National Institute for Health and Care Excellence. Glaucoma: diagnosis and management. NICE guideline NG81. London: NICE; 2017, updated recommendations 2022–2024. Available from: NICE NG81.
  2. American Academy of Ophthalmology. Primary Open-Angle Glaucoma Preferred Practice Pattern®. 2025. Available from: AAO Primary Open-Angle Glaucoma PPP.

Medical disclaimer: This article is educational and does not replace an ophthalmic examination or individual treatment plan. Sudden eye pain with visual changes requires emergency care.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *